Clinical Trial Update: Duloxetine Versus Placebo in the Treatment of FMS [Phase 3]

View source ↗

Summary

Phase 3 randomized trial comparing duloxetine to placebo for fibromyalgia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fibromyalgia

Drugs mentioned

• Cymbalta (duloxetine)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Fibromyalgia | Phase 3 | Status: COMPLETED